Clinical Trials of the Consistency and Non-inferiority Bridging Between Batches of Recombinant New Coronavirus Vaccine (CHO Cells)

NCT05091411 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

1680

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronavirus Disease 2019

Interventions

BIOLOGICAL: Recombinant new coronavirus vaccine (CHO cell) group

Sponsor

Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.